136 Results for "

mGlu Receptor

" in MedChemExpress (MCE) Product Catalog:
Products (136)

136 Results for "mGlu Receptor" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-70059
CAS No.: 201943-63-7
Target:  

mGluR

Research Areas:  

Neurological Disease

LY341495 is a metabotropic glutamate receptor (mGluR) antagonist with IC50s of 21 nM, 14 nM, 7.8 μM, 8.2 μM, 170 nM, 990 nM, 22 μM for mGlu2, mGlu3, mGlu1a, mGlu5a, mGlu8, mGlu7, and mGlu4 receptors, respectively .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-14609
CAS No.: 219911-35-0
Purity:  99.82%
Target:  

mGluR

Research Areas:  

Neurological Disease

MPEP Hydrochloride is a potent, selective, noncompetitive, orally active and systemically active mGlu5 receptor antagonist, with an IC50 of 36 nM for completely inhibiting quisqualate-stimulated phosphoinositide (PI) hydrolysis. MPEP Hydrochloride has anxiolytic-or antidepressant-like effects . MPEP (Hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-14609A
CAS No.: 96206-92-7
Purity:  99.33%
Target:  

mGluR

Research Areas:  

Neurological Disease

MPEP is a potent, selective, noncompetitive, orally active and systemically active mGlu5 receptor antagonist, with an IC50 of 36 nM for completely inhibiting quisqualate-stimulated phosphoinositide (PI) hydrolysis. MPEP has anxiolytic-or antidepressant-like effects . MPEP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-18941
CAS No.: 176199-48-7
Synonyms: LY354740; Eglumetad
Target:  

mGluR

Research Areas:  

Neurological Disease

Eglumegad (LY354740) is a highly potent and selective group II (mGlu2/3) receptor agonist with IC50s of 5 nM and 24 nM on transfected human mGlu2 and mGlu3 receptors, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-18941C
Synonyms: LY354740 hydrochloride; Eglumetad hydrochloride
Target:  

mGluR

Research Areas:  

Neurological Disease

Eglumegad (LY354740) hydrochloride is a highly potent and selective group II (mGlu2/3) receptor agonist with IC50s of 5 and 24 nM on transfected human mGlu2 and mGlu3 receptors, respectively. Eglumegad hydrochloride protects neurons from NMDA toxicity. Eglumegad hydrochloride has anxiolytic- and antipsychotic-like effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100407
CAS No.: 409345-29-5
Purity:  99.94%
Target:  

mGluR

Research Areas:  

Neurological Disease

JNJ16259685 is a selective antagonist of mGlu1 receptor, and inhibits the synaptic activation of mGlu1 in a concentration-dependent manner with IC50 of 19 nM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15445
CAS No.: 871362-31-1
Purity:  99.59%
Synonyms: RO 4956371; mGluR5 inhibitor
Target:  

mGluR

Research Areas:  

Neurological Disease

CTEP (RO 4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, and shows > 1000-fold selectivity over other mGlu receptors. CTEP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-124419
CAS No.: 714971-87-6
Purity:  98.42%
Target:  

mGluR

Research Areas:  

Neurological Disease

RO0711401 is a selective and orally active positive allosteric modulator of mGlu1 receptor with an EC50 of 56 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108710
CAS No.: 1809085-30-0
Purity:  99.55%
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0650786 is a potent and selective CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 (mGlu3 NAM), with an IC50 of 392 nM. VU0650786 has antidepressant and anxiolytic activity in rodents .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103558
CAS No.: 191471-52-0
Purity:  99.84%
Target:  

mGluR

Research Areas:  

Neurological Disease

LY379268 is a potent, selective and brain-penetrant mGlu2/3R agonist with EC50 values of 2.69 nM (mGlu2) and 4.48 nM (mGlu3). LY379268 has no activity on human mGlu 1a, 4a, 5a or 7a receptors. LY379268 has antioxidant and neuroprotective effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100781A
CAS No.: 23052-81-5
Purity:  99.01%
Synonyms: L-APB
Target:  

mGluR

Research Areas:  

Neurological Disease

L-AP4 (L-APB) is a potent and specific agonist for the group III mGluRs, with EC50s of 0.13, 0.29, 1.0, 249 μM for mGlu4, mGlu8, mGlu6 and mGlu7 receptors, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W011417
CAS No.: 606-59-7
Research Areas:  

Others

Cinnabarinic acid is a specific orthosteric agonist of mGlu4 by interacting with residues of the glutamate binding pocket of mGlu4, has no activity at other mGlu receptors. Cinnabarinic acid is an endogenous metabolite of the kynurenine pathway of tryptophan. Cinnabarinic acid induces cell apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101845
CAS No.: 932737-65-0
Purity:  99.85%
Target:  

mGluR

Research Areas:  

Cancer

FITM is a negative allosteric modulator of mGlu1 receptor with a Ki of 2.5 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100588
CAS No.: 61350-00-3
Purity:  99.94%
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0364770 is a selective and potent positive allosteric modulator (PAM) of mGlu4. VU0346770 exhibits EC50s of 290 nM and 1.1 μM at rat mGlu4 and human mGlu4 receptor, respectively. VU0364770 exhibits antagonist activity at mGlu5 with a potency of 17.9 μM and PAM activity at mGlu6 with a potency of 6.8 μM. VU0364770 also possesses activity at MAO with Ki values of 8.5 and 0.72 μM for human MAO-A and human MAO-B, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123820
CAS No.: 1377615-44-5
Purity:  99.18%
Target:  

mGluR

Research Areas:  

Neurological Disease

LY3020371 hydrochloride is a potent, selective metabotropic glutamate 2/3 receptor (mGlu2/3) antagonist with Ki of 5.3 and 2.5 nM, potently blocks cAMP formation with IC50 of 16.2 nM . LY3020371 hydrochloride exerts an antidepressant-like signature in vivo .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18162
CAS No.: 1254977-87-1
Target:  

mGluR

Research Areas:  

Neurological Disease

JNJ-42153605 is a positive allosteric modulator of the metabotropic glutamate 2 (mGlu2) receptor with an EC50 of 17 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100588A
CAS No.: 1414842-70-8
Purity:  99.70%
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0364770 hydrochloride is a selective and potent positive allosteric modulator (PAM) of mGlu4. VU0346770 hydrochloride exhibits EC50s of 290 nM and 1.1 μM at rat mGlu4 and human mGlu4 receptor, respectively. VU0364770 hydrochloride exhibits antagonist activity at mGlu5 with a potency of 17.9 μM and PAM activity at mGlu6 with a potency of 6.8 μM. VU0364770 hydrochloride also possesses activity at MAO with Ki values of 8.5 and 0.72 μM for human MAO-A and human MAO-B, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119243
CAS No.: 2173037-97-1
Purity:  99.65%
Target:  

mGluR

Research Areas:  

Neurological Disease

LY2794193 is a highly potent and selective mGlu3 receptor agonist (hmGlu3 Ki=0.927 nM,EC50=0.47 nM; hmGlu2 Ki=412 nM,EC50=47.5 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15446
CAS No.: 802906-73-6
Purity:  ≥98.0%
Synonyms: RG7090; RO4917523
Target:  

mGluR

Research Areas:  

Neurological Disease

Basimglurant (RG7090; RO4917523) is a selective, orally active, blood-brain barrier permeable negative allosteric modulator of metabotropic glutamate receptor 5 (mGluR5), with a Ki of 1.4 nM (against [ 3H]-ABP688 (HY-110141)) and 35.6 nM (against [ 3H]-MPEP (HY-14609A)). Basimglurant inhibits mGlu5-mediated signaling pathways and receptor constitutive activity, regulates dopamine levels in the nucleus accumbens, exerts anxiolytic, antidepressant-like, analgesic and arousal-promoting effects, and alters δ-wave power during non-rapid eye movement sleep. Basimglurant can be used in research on depression, fragile X syndrome, anxiety disorders, etc .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18654
CAS No.: 1235318-89-4
Target:  

mGluR

Research Areas:  

Neurological Disease

ADX88178 is an orally active, blood-brain barrier-penetrant, selective positive allosteric modulator of mGluR4, with an EC50 of 3.5 nM against hmGluR4. ADX88178 modulates mGlu4 activity, enhances glutamate-mediated receptor activation, and increases the apparent affinity of glutamate for the receptor. ADX88178 reverses haloperidol-induced catalepsy, potentiates the effects of levodopa (L-DOPA) and quinpirole, but fails to alleviate established abnormal involuntary movements, does not exacerbate L-DOPA-induced dyskinesia, and does not affect forelimb akinesia when administered alone. ADX88178 can be used in research related to L-DOPA-induced dyskinesia and Parkinson's disease .
loading...
    loading...